product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
TCL1 Antibody
catalog :
4042
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
citations: 79
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; 1:1000; fig 4
Chen S, Chang B, Chang S, Tong T, Ham S, Sherry B, et al. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. 2016;30:833-43 pubmed publisher
Yang C, Ji S, Li Y, Fu L, Jiang T, Meng F. ?-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco Targets Ther. 2017;10:711-724 pubmed publisher
Ma S, Srivastava S, Llamosas E, Hawkins N, Hesson L, Ward R, et al. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. BMC Cancer. 2016;16:508 pubmed publisher
Lynch J, Wang J. G Protein-Coupled Receptor Signaling in Stem Cells and Cancer. Int J Mol Sci. 2016;17: pubmed publisher
Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, et al. Esophageal cancer stem cells and implications for future therapeutics. Onco Targets Ther. 2016;9:2247-54 pubmed publisher
Zhang Z, Chen H, Xu C, Song L, Huang L, Lai Y, et al. Curcumin inhibits tumor epithelial?mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncol Rep. 2016;35:2615-23 pubmed publisher
Jia X, Li N, Peng C, Deng Y, Wang J, Deng M, et al. miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells. Oncotarget. 2016;7:7044-54 pubmed publisher
Fujimaki S, Machida M, Wakabayashi T, Asashima M, Takemasa T, Kuwabara T. Functional Overload Enhances Satellite Cell Properties in Skeletal Muscle. Stem Cells Int. 2016;2016:7619418 pubmed publisher
Bayerlová M, Klemm F, Kramer F, Pukrop T, Beißbarth T, Bleckmann A. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data. PLoS ONE. 2015;10:e0144014 pubmed publisher
Liu W, Liang X, Yang D. The Effects of Chinese Medicine on Activation of Wnt/β-Catenin Signal Pathway under High Glucose Condition. Evid Based Complement Alternat Med. 2015;2015:295135 pubmed publisher
Elsarraj H, Hong Y, Valdez K, Michaels W, Hook M, Smith W, et al. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Breast Cancer Res. 2015;17:128 pubmed publisher
Miyoshi K, Horiguchi T, Tanimura A, Hagita H, Noma T. Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells. Biomed Res Int. 2015;2015:121575 pubmed publisher
Hamilton G, Rath B, Klameth L, Hochmair M. Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience. 2015;2:629-34 pubmed
López Guerra J, Verdugo Sivianes E, Otero Albiol D, Vieites B, Ortiz Gordillo M, De León J, et al. High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer. Oncotarget. 2015;6:30343-56 pubmed publisher
Ledaki I, McIntyre A, Wigfield S, Buffa F, McGowan S, Baban D, et al. Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition. Oncotarget. 2015;6:19413-27 pubmed
Li M, Tian L, Ren H, Chen X, Wang Y, Ge J, et al. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8. J Transl Med. 2015;13:271 pubmed publisher
Jing D, Hao J, Shen Y, Tang G, Li M, Huang S, et al. The role of microRNAs in bone remodeling. Int J Oral Sci. 2015;7:131-43 pubmed publisher
Shenoy N, Vallumsetla N, Zou Y, Galeas J, Shrivastava M, Hu C, et al. Role of DNA methylation in renal cell carcinoma. J Hematol Oncol. 2015;8:88 pubmed publisher
Cheng Y, Phoon Y, Jin X, Chong S, Ip J, Wong B, et al. Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment. Oncotarget. 2015;6:14428-39 pubmed
Zanni R, Gálvez Llompart M, Morell C, Rodríguez Henche N, Díaz Laviada I, Recio Iglesias M, et al. Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors. PLoS ONE. 2015;10:e0124244 pubmed publisher
Brancaccio A, Palacios D. Chromatin signaling in muscle stem cells: interpreting the regenerative microenvironment. Front Aging Neurosci. 2015;7:36 pubmed publisher
Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, et al. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget. 2015;6:10964-77 pubmed
Fan X, Liu Z, Jin H, Yan J, Liang H. Alterations of dendritic cells in sepsis: featured role in immunoparalysis. Biomed Res Int. 2015;2015:903720 pubmed publisher
He G, Guan X, Chen X, Wang Y, Luo C, Zhang B. Expression and Splice Variant Analysis of Human TCF4 Transcription Factor in Esophageal Cancer. J Cancer. 2015;6:333-41 pubmed publisher
Ma J, Cheng J, Gong Y, Tian L, Huang Q. Downregulation of Wnt signaling by sonic hedgehog activation promotes repopulation of human tumor cell lines. Dis Model Mech. 2015;8:385-91 pubmed publisher
Johansson J, Tabor V, Wikell A, Jalkanen S, Fuxe J. TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells. Front Oncol. 2015;5:3 pubmed publisher
Di Liddo R, Bertalot T, Schuster A, Schrenk S, Tasso A, Zanusso I, et al. Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures. J Neuroinflammation. 2015;12:23 pubmed publisher
Xu X, Ren J. Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int J Obes (Lond). 2015;39:387-96 pubmed publisher
Faisy C, Grassin Delyle S, Blouquit Laye S, Brollo M, Naline E, Chapelier A, et al. Wnt/β-catenin signaling modulates human airway sensitization induced by β2-adrenoceptor stimulation. PLoS ONE. 2014;9:e111350 pubmed publisher
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M. Short hairpin RNA of frizzled-2 suppresses the proliferation of hepatocellular carcinoma cells. Oncol Lett. 2014;8:1519-1522 pubmed
Pagliari S, Jelinek J, Grassi G, Forte G. Targeting pleiotropic signaling pathways to control adult cardiac stem cell fate and function. Front Physiol. 2014;5:219 pubmed publisher
Shukrun R, Pode Shakked N, Pleniceanu O, Omer D, Vax E, Peer E, et al. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk. Stem Cell Reports. 2014;3:24-33 pubmed publisher
Zhang J, Schindler T, Küng E, Ebeling M, Certa U. Highly sensitive amplicon-based transcript quantification by semiconductor sequencing. BMC Genomics. 2014;15:565 pubmed publisher
Umer M, Qureshi S, Hashmi Z, Raza A, Ahmad J, Rahman M, et al. Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis. Virol J. 2014;11:117 pubmed publisher
Aulicino F, Theka I, Ombrato L, Lluis F, Cosma M. Temporal perturbation of the Wnt signaling pathway in the control of cell reprogramming is modulated by TCF1. Stem Cell Reports. 2014;2:707-20 pubmed publisher
Gao B, Huang Q, Lin Y, Wei B, Guo Y, Sun Z, et al. Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway. PLoS ONE. 2014;9:e99137 pubmed publisher
Campbell M. Vitamin D and the RNA transcriptome: more than mRNA regulation. Front Physiol. 2014;5:181 pubmed publisher
Li L, Wang L, Song P, Geng X, Liang X, Zhou M, et al. Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis. Mol Cancer. 2014;13:81 pubmed publisher
Nam S, Chang H, Kim K, Kook M, Hong D, Kwon C, et al. PATHOME: an algorithm for accurately detecting differentially expressed subpathways. Oncogene. 2014;33:4941-51 pubmed publisher
Ricketts C, Hill V, Linehan W. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project. PLoS ONE. 2014;9:e85621 pubmed publisher
Zhang Y, Wu S, Sun J. Vitamin D, Vitamin D Receptor, and Tissue Barriers. Tissue Barriers. 2013;1: pubmed
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T. Frizzled-2: A potential novel target for molecular pancreatic cancer therapy. Oncol Lett. 2014;7:74-78 pubmed
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M, et al. Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway. Onco Targets Ther. 2013;6:1685-93 pubmed publisher
Li M, Tian L, Wang L, Yao H, Zhang J, Lu J, et al. Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC. PLoS ONE. 2013;8:e77829 pubmed publisher
Ko B, Lu Y, Yao W, Liu T, Tzean S, Shen T, et al. Cordycepin regulates GSK-3?/?-catenin signaling in human leukemia cells. PLoS ONE. 2013;8:e76320 pubmed publisher
Cheng Y, Cheung A, Ko J, Phoon Y, Chiu P, Lo P, et al. Physiological ?-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol. 2013;14:44 pubmed publisher
Hindi S, Shin J, Ogura Y, Li H, Kumar A. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS ONE. 2013;8:e72121 pubmed publisher
Liu Y, Dong Q, Wang S, Fang C, Miao Y, Wang L, et al. Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer. BMC Cancer. 2013;13:346 pubmed publisher
Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med. 2013;32:763-7 pubmed publisher
Sallustio F, Serino G, Costantino V, Curci C, Cox S, De Palma G, et al. miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS ONE. 2013;8:e68296 pubmed publisher
Fujimaki S, Machida M, Hidaka R, Asashima M, Takemasa T, Kuwabara T. Intrinsic ability of adult stem cell in skeletal muscle: an effective and replenishable resource to the establishment of pluripotent stem cells. Stem Cells Int. 2013;2013:420164 pubmed publisher
Lim S, Becker A, Zimmer A, Lu J, Buettner R, Kirfel J. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS ONE. 2013;8:e66558 pubmed publisher
Giuliani N, Lisignoli G, Magnani M, Racano C, Bolzoni M, Dalla Palma B, et al. New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int. 2013;2013:312501 pubmed publisher
Katoh M. Functional proteomics, human genetics and cancer biology of GIPC family members. Exp Mol Med. 2013;45:e26 pubmed publisher
Sanchez Diaz P, Hsiao T, Chang J, Yue D, Tan M, Chen H, et al. De-regulated microRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and development. PLoS ONE. 2013;8:e61622 pubmed publisher
Hirata H, Ueno K, Nakajima K, Tabatabai Z, Hinoda Y, Ishii N, et al. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Br J Cancer. 2013;108:2070-8 pubmed publisher
Valdora F, Banelli B, Stigliani S, Pfister S, Moretti S, Kool M, et al. Epigenetic Silencing of DKK3 in medulloblastoma. Int J Mol Sci. 2013;14:7492-505 pubmed publisher
Jiang W, Crossman D, Mitchell E, Sohn P, Crowley M, Serra R. WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells. PLoS ONE. 2013;8:e58329 pubmed publisher
Dowell K, Simons A, Wang Z, Yun K, Hibbs M. Cell-type-specific predictive network yields novel insights into mouse embryonic stem cell self-renewal and cell fate. PLoS ONE. 2013;8:e56810 pubmed publisher
Wang K, Wu X, Wang J, Huang J. Cancer stem cell theory: therapeutic implications for nanomedicine. Int J Nanomedicine. 2013;8:899-908 pubmed publisher
Sun B, Ma L, Yan X, Lee D, Alexander V, Hohmann L, et al. N-glycoproteome of E14.Tg2a mouse embryonic stem cells. PLoS ONE. 2013;8:e55722 pubmed publisher
Schaap Oziemlak A, Schouteden S, Khurana S, Verfaillie C. Wnt5a does not support hematopoiesis in stroma-free, serum-free cultures. PLoS ONE. 2013;8:e53669 pubmed publisher
Hsu C, Yang U. Discovering pathway cross-talks based on functional relations between pathways. BMC Genomics. 2012;13 Suppl 7:S25 pubmed publisher
Wang D, Wise M, Li F, Dey M. Phytochemicals attenuating aberrant activation of ?-catenin in cancer cells. PLoS ONE. 2012;7:e50508 pubmed publisher
Katoh M. Function and cancer genomics of FAT family genes (review). Int J Oncol. 2012;41:1913-8 pubmed publisher
Benisch P, Schilling T, Klein Hitpass L, Frey S, Seefried L, Raaijmakers N, et al. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS ONE. 2012;7:e45142 pubmed publisher
Yao H, Ashihara E, Strovel J, Nakagawa Y, Kuroda J, Nagao R, et al. AV-65, a novel Wnt/?-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model. Blood Cancer J. 2011;1:e43 pubmed publisher
Chang T, Liu C, Hsing E, Liang S, Chi Y, Sung L, et al. 14-3-3? regulates ?-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3?. PLoS ONE. 2012;7:e40193 pubmed publisher
Yu M, Ting D, Stott S, Wittner B, Ozsolak F, Paul S, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012;487:510-3 pubmed publisher
Cao H, Chu Y, Lv X, Qiu P, Liu C, Zhang H, et al. GSK3 inhibitor-BIO regulates proliferation of immortalized pancreatic mesenchymal stem cells (iPMSCs). PLoS ONE. 2012;7:e31502 pubmed publisher
Oishi N, Wang X. Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci. 2011;7:517-35 pubmed
Kelber J, Klemke R. PEAK1, a novel kinase target in the fight against cancer. Oncotarget. 2010;1:219-23 pubmed
Chang T, Chen Y, Yang M, Chen C, Hsing E, Ko B, et al. Rho kinases regulate the renewal and neural differentiation of embryonic stem cells in a cell plating density-dependent manner. PLoS ONE. 2010;5:e9187 pubmed publisher
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher
Fardin P, Ognibene M, Vanni C, De Santanna A, Varesio L, Eva A. Induction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice. PLoS ONE. 2009;4:e7058 pubmed publisher
Matsuda Y, Schlange T, Oakeley E, Boulay A, Hynes N. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res. 2009;11:R32 pubmed publisher
Björklund P, Svedlund J, Olsson A, Akerstrom G, Westin G. The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS ONE. 2009;4:e4243 pubmed publisher
Bengochea A, de Souza M, Lefrancois L, Le Roux E, Galy O, Chemin I, et al. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer. 2008;99:143-50 pubmed publisher
Grunewald T, Butt E. The LIM and SH3 domain protein family: structural proteins or signal transducers or both?. Mol Cancer. 2008;7:31 pubmed publisher
product information
SKU :
4042S
Product-Name :
TCL1 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, (M)
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
PI3K / Akt Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
14
Host :
Rabbit
Target :
TCL1
Primary-Protein :
TCL1A
Alt-Names :
Oncogene TCL-1,Oncogene TCL1,Protein p14 TCL1,T-cell leukemia/lymphoma 1A,T-cell leukemia/lymphoma protein 1A,T-cell lymphoma-1,T-cell lymphoma-1A,TCL1,TCL1A
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.